Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial

Mia Ravn Jacobsen1, Reza Jabbari1, Charlotte Glinge1

  • 1Department of Cardiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.

Insights

Potassium levels outside the normal range, both low (hypokalemia) and high (hyperkalemia), increase the risk of ventricular fibrillation (VF) in ST-segment-elevation myocardial infarction (STEMI) patients before treatment. This association holds even when considering potassium levels measured after initial resuscitation efforts.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Potassium disturbances are known risk factors for ventricular fibrillation (VF).
  • The association between potassium levels and VF during the acute phase of ST-segment-elevation myocardial infarction (STEMI) before primary percutaneous coronary intervention (PPCI) requires further investigation.

Purpose of the Study:

  • To investigate the association between pre-PPCI potassium levels and the occurrence of VF in STEMI patients.
  • To determine if hypokalemia or hyperkalemia independently predict VF risk in the acute STEMI setting.

Main Methods:

  • Retrospective analysis of 8624 STEMI patients from the Eastern Danish Heart Registry (1999-2016).
  • Potassium levels measured immediately before PPCI.
  • Multivariate logistic regression models adjusted for comorbidities and medication use to assess the association between potassium levels (hypokalemia, normokalemia, hyperkalemia) and VF.

Main Results:

  • Patients with hypokalemia (<3.5 mmol/L) and hyperkalemia (>5.0 mmol/L) showed a significantly higher risk of VF before PPCI compared to normokalemic patients (3.5-5.0 mmol/L).
  • Adjusted odds ratios for VF were 1.90 for hypokalemia and 3.36 for hyperkalemia.
  • Sensitivity analysis in patients without pre-PPCI VF indicated a significant association between hypokalemia and VF occurring during PPCI (adjusted OR 1.68).

Conclusions:

  • Both hypokalemia and hyperkalemia are independently associated with an increased risk of VF in STEMI patients prior to PPCI.
  • The association between hypokalemia and VF may persist regardless of whether potassium is measured before or after resuscitation events.

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.6K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
375
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
545
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
387